Etanercept Biosimilar Is Effective, Well-Tolerated for Rheumatoid Arthritis
Etanercept’s New Autoinjection System; Plus FDA Approves Ixekizumab for Active PsA
Sequential Therapy May Reduce Hip Fracture Risk; Plus New Biosimilar Available in Canada
TNF Inhibitor Drug Tapering Successful in Some Patients with RA
Anti-TNF-Alpha Agents May Improve Endothelial Function Patients with RA
Anti-Drug Antibodies May Affect RA Treatment
High Cost of Rheumatoid Arthritis Medications Burdens Patients in Saudi Arabia
Certolizumab Pegol Promising for Plaque Psoriasis in Phase 3 Trial
Rheumatology Drug Updates: Giant Cell Arteritis Relapse Possible if Tocilizumab Discontinued; Plus Updates on Rituximab, Etanercept
- 1
- 2
- 3
- 4
- Next Page »